In addition to this limitation, the widespread involvement of HGF/Met signaling in human cancers, particularly those with direct exposure to the urinary tract such as renal cell carcinoma and prostate cancer, raises the likely possibility that other malignancies may be associated with increased urinary sMet [12]. Here, HGF is linked to renal cell carcinoma.